Plexus Corp. (PLXS) Stock Price | Live Quotes & Charts | NASDAQ
This page provides live stock quotes and charts for Plexus Corp. (PLXS) on NASDAQ. It includes the current stock price, daily change, and mentions the absence of analyst ratings and earnings information for the company. The page also promotes a virtual trading conference and free trade alerts.
Plexus Corp. Experiences Valuation Adjustment Amid Strong Market Performance and Competitive Positioning
Plexus Corp., a small-cap electronics company, has seen strong performance with a 40.97% year-to-date return and a remarkable 62.63% return over the past year, significantly outperforming the S&P 500. The company recently underwent a valuation adjustment, with its stock currently priced at $207.22. Despite a competitive landscape, Plexus exhibits solid operational performance, as indicated by a P/E ratio of 60 and a return on capital employed of 14.71%.
Plexus Corp. (NASDAQ:PLXS) Given Consensus Rating of "Moderate Buy" by Analysts
Plexus Corp. (NASDAQ:PLXS) has received a "Moderate Buy" consensus rating from six research firms, with an average 12-month price target of $194.20. The company recently surpassed quarterly EPS expectations and provided strong Q2 2026 guidance. Despite significant insider selling over the past 90 days, institutional investors have largely increased their holdings in the technology company.
PLXS Stock Up 32% in 3 Months: Is There Further Upside Left?
Plexus (PLXS) stock has surged 32% in the past three months, outperforming its industry and the broader market due to strong program wins and a $3.6 billion pipeline. While the company demonstrates robust growth drivers in healthcare, aerospace, and defense, and strong cash generation, it faces risks from industrial sector weakness and competition. Despite these challenges, analysts have revised estimates upwards, and its valuation, though slightly above the sector average, suggests potential for continued upside.
Plexus (PLXS) Raymond James 46th Annual Institutional Investors Conference Summary
Plexus (PLXS) presented at the Raymond James 46th Annual Institutional Investors Conference, detailing its business across healthcare, industrial, and aerospace/defense sectors. The company reported a 6.2% non-GAAP operating margin in the December quarter and anticipates sequential growth across all sectors in fiscal 2025, targeting 9%-12% annual growth. Despite some choppiness due to inventory corrections, Plexus expects margin recovery and growth driven by new facilities, higher-margin services, and market share gains.
Plexus Corp. Stock Hits Day Low of $199.35 Amid Price Pressure
Plexus Corp. experienced a significant intra-day stock price decline of 7.87%, hitting a low of $199.35. Despite this day's downturn, the company has shown strong long-term performance, with a 53.69% increase over the past year and impressive financial metrics like a 16.29% ROCE. Institutional holdings remain at 100%, reflecting confidence in Plexus Corp.'s fundamentals.
Understanding the Setup: (PLXS) and Scalable Risk
This article analyzes Plexus Corp. (PLXS), highlighting strong short-term, mid-term, and long-term sentiment. It outlines three distinct AI-generated trading strategies—Position Trading, Momentum Breakout, and Risk Hedging—with specific entry, target, and stop-loss parameters. The analysis also identifies a significant 34.9:1 risk-reward short setup for PLXS.
PLXS Shares Rise 32% Over 3 Months: Does More Growth Await?
Plexus Corporation (PLXS) has seen its shares jump 32.3% in the last quarter, significantly outperforming its industry and the broader market. This strong performance is driven by a robust pipeline of new manufacturing programs, particularly in healthcare, life sciences, aerospace, and defense sectors. Despite challenges in the Industrial segment and general economic uncertainties, analysts have raised earnings estimates, and the company's strategic focus on growth and shareholder returns suggests continued potential.
Vanguard amends Schedule 13G/A—reports 0 shares of Plexus Corp (NASDAQ: PLXS)
Vanguard has amended its Schedule 13G/A, reporting 0 shares and 0% beneficial ownership of Plexus Corp (NASDAQ: PLXS) as of March 13, 2026. This change is attributed to an internal realignment completed on January 12, 2026, where certain Vanguard subsidiaries will now report their holdings separately. The filing does not indicate any immediate impact on voting or dividends for PLXS shareholders.
PLXS Shares Rise 32% Over 3 Months: Does More Growth Await?
Plexus Corporation (PLXS) shares have surged 32.3% over the last quarter, outperforming the Electronic Manufacturing Industry. The company's growth is driven by new manufacturing programs in healthcare, aerospace, and defense, with a strong pipeline of opportunities. While facing challenges in the Industrial segment and competition, Plexus maintains a strong financial position, evidenced by robust cash flow and share repurchases, leading analysts to rate it as a Zacks Rank #2 (Buy).
Plexus Corp. Hits New 52-Week High at USD 220.17, Up 112%
Plexus Corp. has achieved a new 52-week high of USD 220.17, representing a 112% increase over the past year and significantly outperforming the S&P 500. The company, with a market capitalization of USD 10,224 million, exhibits strong financial metrics including a P/E ratio of 60.00 and a return on equity of 11.55%. Despite no dividend yield, its conservative leveraging and solid performance continue to attract investor attention.
Plexus Corp. stock downgraded from Strong Buy Candidate to Hold/Accumulate after Wednesday trading session
Plexus Corp. (PLXS) stock gained 1.46% on the last trading day, rising to $217.26, and has been in a strong short-term rising trend. Despite positive signals from moving averages and a pivot bottom, the stock has been downgraded from "Strong Buy" to "Hold/Accumulate" due to minor technical weaknesses and falling volume on higher prices, suggesting caution. Analysts expect a 26.36% rise in the next three months with a 90% probability of reaching between $248.25 and $295.10.
Plexus Corp. Hits New 52-Week High at $215.07, Up 109%
Plexus Corp. has reached a new 52-week high of $215.07, demonstrating a 109% increase over the past year, significantly outperforming the S&P 500. The company, a small-cap player in the Electronics & Appliances industry with a market capitalization of $10,224 million, shows effective management and a conservative approach to leverage by reinvesting profits for growth. Its P/E ratio is 60.00, return on equity is 11.55%, and price-to-book ratio is 6.90.
Plexus Corp (PLXS) Shares Up 5.57% on Mar 24
Plexus Corp (PLXS) shares rose 5.57% on March 24, reaching an intraday high of $214.62 before closing at $214.09. Wall Street analysts have an average one-year price target of $200.80 for PLXS, implying a 6.21% downside, while GuruFocus estimates a one-year fair value of $144.62, suggesting a 32.45% downside. The stock is currently trading near its 52-week high, with a consensus brokerage recommendation to "Hold."
Plexus (NASDAQ:PLXS) Sets New 12-Month High - Time to Buy?
Plexus (NASDAQ:PLXS) recently hit a new 52-week intraday high of $213.62, closing at $214.2350, with a market cap of $5.69 billion. The company reported strong Q1 earnings, slightly beating estimates with $1.78 EPS, and provided optimistic Q2 2026 guidance. Despite insider selling, analysts maintain a "Moderate Buy" rating, although the consensus price target of $194.20 is below the current trading price.
Plexus Corp. Experiences Valuation Adjustment Amid Strong Market Performance and Competitive Metrics
Plexus Corp., a small-cap company in the Electronics & Appliances sector, has adjusted its valuation metrics, including a P/E ratio of 49 and a ROCE of 16.15%. The company has significantly outperformed the S&P 500 with a year-to-date return of 26.46%. Its competitive valuation and strong market performance highlight its solid financial standing compared to peers.
JPMorgan Chase & Co. Acquires 52,967 Shares of Plexus Corp. $PLXS
JPMorgan Chase & Co. increased its stake in Plexus Corp. by 28.3% in the third quarter, acquiring 52,967 additional shares and bringing its total to 240,460 shares valued at approximately $34.79 million. This makes JPMorgan Chase & Co. the largest institutional holder of Plexus, owning 0.90% of the company. Analyst sentiment for Plexus is categorized as a "Moderate Buy," with a consensus target price of $194.20, despite recent insider share sales.
PLXS SEC Filings - Plexus Corp 10-K, 10-Q, 8-K Forms
This page provides access to Plexus Corp.'s (PLXS) SEC filings, including 10-K, 10-Q, and 8-K reports, enhanced with AI-powered summaries. Recent filings include the Q1 2026 earnings report showing increased net sales and income, and several insider transaction reports detailing the vesting of restricted stock units for multiple directors. A shareholder also filed a notice to sell a significant number of common shares.
Insider Sell: Todd Kelsey Sells 1,500 Shares of Plexus Corp (PLX
Todd Kelsey, President & CEO of Plexus Corp (PLXS), sold 1,500 shares of the company on March 18, 2026, reducing his total holdings to 81,791 shares. This sale follows a pattern of 42 insider sells and no buys for the company over the past year. Plexus Corp is currently trading at $194.24, which is significantly overvalued with a price-to-GF-Value ratio of 1.5, suggesting an intrinsic value of $129.77.
PLEXUS CORP (PLXS) CEO Todd Kelsey sells 1,500 shares under 10b5-1 plan
Todd P. Kelsey, President & CEO of PLEXUS CORP (PLXS), reported an open-market sale of 1,500 shares of common stock at $194.24 per share. This transaction was conducted under a pre-arranged Rule 10b5-1 trading plan adopted on November 20, 2025. Following the sale, Kelsey directly holds 81,791 shares of the company.
Todd Kelsey Sells 1,500 Shares of Plexus (NASDAQ:PLXS) Stock
Plexus (NASDAQ:PLXS) CEO Todd Kelsey sold 1,500 shares of the company's stock on March 18th at an average price of $194.24, totaling $291,360. This transaction reduced his ownership by 1.8% to 81,791 shares. The company recently reported strong Q1 results, with EPS of $1.78 beating estimates and revenue up 9.6% year-over-year, and has a "Moderate Buy" consensus rating from analysts.
Plexus Corp. (PLXS) soars to 52-week high, time to cash out?
The article discusses Plexus Corp. (PLXS) reaching a new 52-week high. It poses the question of whether this is an opportune moment for investors to sell their shares. The content is unavailable for a more detailed summary.
Plexus Corp. (PLXS) soars to 52-week high, time to cash out?
The article discusses Plexus Corp. (PLXS) reaching a 52-week high. It prompts readers to consider whether it's an opportune moment to sell their shares. The content is very brief and does not include detailed financial analysis.
Plexus (PLXS) Analyst Rating Reiterated at 'Buy' by Benchmark
Benchmark analyst David Williams has reiterated a 'Buy' rating for Plexus (PLXS), maintaining the target price at $220.00. This follows previous positive adjustments by Benchmark and Needham analysts, while Stifel maintained a 'Hold' rating with an increased target. The average one-year price target from 5 analysts for PLXS is $200.80, suggesting a slight upside from its current price, though GuruFocus estimates a potential downside based on its GF Value.
The Technical Signals Behind (PLXS) That Institutions Follow
This article analyzes Plexus Corp. (NASDAQ: PLXS) through the lens of institutional trading strategies, identifying positive near-term sentiment within a long-term bullish context despite a mid-term weak bias. AI models have generated distinct trading strategies—position trading, momentum breakout, and risk hedging—along with multi-timeframe signal analysis to optimize position sizing and manage risk. Key findings include an exceptional risk-reward short setup and specific entry, target, and stop-loss levels for different strategies.
Plexus Corp (PLXS) Stock Price Up 3.8% on Mar 16
Plexus Corp (PLXS) saw its stock price increase by 3.80% on March 16, closing at $197.99. This puts PLXS 6.54% below its 52-week high but 91.42% above its 52-week low. Wall Street analysts have an average target price of $200.80 for PLXS, suggesting a potential upside of 1.42%, while GuruFocus estimates a downside of 27.01% based on its GF Value of $144.52.
Plexus (NASDAQ:PLXS) Receives Buy Rating from Benchmark
Benchmark has reissued a "Buy" rating for Plexus (NASDAQ:PLXS), setting a price target of $220, indicating an 11.3% potential upside. This comes as Plexus reported strong Q1 earnings, beating estimates with $1.78 EPS and $1.07 billion in revenue, and provided optimistic Q2 guidance. Despite recent insider selling, institution ownership remains high, and analysts maintain a "Moderate Buy" consensus for the stock.
Plexus (PLXS) Analyst Rating Reiterated at 'Buy' by Benchmark
Benchmark analyst David Williams has reiterated a 'Buy' rating for Plexus (PLXS), maintaining a target price of USD 220.00. This follows previous increases in target prices by various analysts, including Needham and Stifel, reflecting a generally positive outlook. Despite this, the average brokerage recommendation indicates a "Hold" status, and GuruFocus estimates suggest a potential downside from its current price based on its fair value calculations.
Earnest Partners LLC Sells 35,208 Shares of Plexus Corp. $PLXS
Earnest Partners LLC significantly reduced its stake in Plexus Corp. by selling 35,208 shares, decreasing its holdings by 4.7% to 711,566 shares valued at over $102 million. This move comes as other institutional investors adjusted their positions, and insiders, including the CEO and COO, also sold shares totaling approximately $9.72 million. Despite the institutional selling, Plexus reported a slight EPS beat and revenue growth, with analysts maintaining a "Moderate Buy" consensus and an average price target of $189.20.
Plexus Corp. Receives 'Moderate Buy' Rating from Analysts
Plexus Corp. (NASDAQ:PLXS) has received a 'Moderate Buy' consensus rating from analysts, with an average 12-month price target of $189.20. This rating reflects the company's position as a global provider of electronics manufacturing services and precision engineered solutions. Recent analyst actions include upgrades from Zacks Research and increased price targets from Stifel Nicolaus and Benchmark, suggesting potential upside for the stock.
13,813 Shares in Plexus Corp. $PLXS Acquired by Fieldview Capital Management LLC
Fieldview Capital Management LLC recently purchased 13,813 shares of Plexus Corp. (NASDAQ:PLXS), valued at approximately $1.999 million, representing a new position for the firm. Despite significant insider selling over the past 90 days, analysts largely maintain a "Moderate Buy" consensus rating with a price target of $189.20 for Plexus. The company recently exceeded its quarterly EPS estimates and provided positive guidance for Q2 2026.
Victory Capital Management Inc. Sells 29,007 Shares of Plexus Corp. $PLXS
Victory Capital Management Inc. reduced its stake in Plexus Corp. by 16% in the third quarter, selling 29,007 shares and ending the period with 151,774 shares valued at approximately $21.96 million. This move comes as Plexus insiders have also been net sellers, offloading shares worth roughly $9.72 million over the past three months. Despite insider sales, Plexus reported strong quarterly earnings, beating analyst expectations with $1.78 EPS on $1.07 billion revenue, and provided optimistic Q2 2026 guidance.
Dimensional Fund Advisors LP Cuts Stock Position in Plexus Corp. $PLXS
Dimensional Fund Advisors LP reduced its stake in Plexus Corp. by 0.6% in the third quarter of 2025, while other institutional investors largely increased their positions, bringing total institutional ownership to 94.45%. Despite this, the article highlights significant insider selling, with the chairman and CFO selling shares totaling over $2 million, and a broader trend of insiders selling nearly $10 million in shares over the past 90 days. Several analysts have raised ratings and price targets for Plexus following a slight EPS beat and revenue growth, resulting in a consensus "Moderate Buy" rating with a $189.20 price target.
Plexus Corp. (NASDAQ:PLXS) Receives Consensus Rating of "Moderate Buy" from Analysts
Plexus Corp. (NASDAQ:PLXS) has received a consensus "Moderate Buy" rating from analysts, with an average 12-month price target of $189.20. Despite this, top insiders recently sold shares, with CFO Patrick J. Jermain and CEO Todd P. Kelsey selling a combined 12,961 shares in early February. The company reported a slight beat on Q1 EPS and a 9.6% year-over-year revenue increase, issuing positive Q2 guidance.
Precision Trading with Plexus Corp. (PLXS) Risk Zones
This article analyzes Plexus Corp. (PLXS) using AI models, identifying weak near and mid-term sentiment but a strong long-term outlook. It outlines three distinct trading strategies—Position, Momentum Breakout, and Risk Hedging—with specific entry, target, and stop-loss zones. The analysis points to an exceptional 34.8:1 risk-reward short setup targeting a 10.1% downside with 0.3% risk.
Plexus Earns ISO 14001 Certification in Mexico
Plexus Corp.'s Manufacturing Solutions facility in Guadalajara, Mexico, has achieved ISO 14001 certification, recognizing its commitment to environmental management. This certification emphasizes the company's focus on measuring and improving its environmental impact. The facility, which opened in August 2014, also holds ISO 9001 and ISO 13485 standards certifications.
Plexus Corp. Experiences Valuation Adjustment Amid Strong Market Performance and Competitive Metrics
Plexus Corp., a small-cap electronics company, has adjusted its valuation, now showing a P/E ratio of 49 and a price-to-book value of 5.62. The company has demonstrated strong market performance with a year-to-date return of 32.06%, significantly outperforming the S&P 500. Plexus also exhibits competitive financial metrics like a solid return on capital employed (ROCE) of 16.15% and a return on equity (ROE) of 11.42%, distinguishing itself from some peers.
Insider Sell: Karen Rapp Sells 500 Shares of Plexus Corp (PLXS)
Karen Rapp, a Director at Plexus Corp (PLXS), sold 500 shares on February 27, 2026, bringing her total ownership to 8,535 shares. This sale is part of a trend of 41 insider sells and no buys at Plexus Corp over the past year. The company's stock is currently trading at $195.59, which is significantly overvalued compared to its GF Value of $128.97, and its P/E ratio of 30.33 is higher than the industry median.
Insider Selling: Plexus (NASDAQ:PLXS) Director Sells 500 Shares of Stock
Plexus (NASDAQ:PLXS) Director Karen Marie Rapp sold 500 shares of the company's stock on February 27th at an average price of $195.59, totaling $97,795. This transaction reduced her holding by 5.53% to 8,535 shares. The company, which has a market cap of $5.22 billion, recently reported Q1 EPS of $1.78, beating consensus estimates, and provided Q2 2026 EPS guidance of $1.80–1.95.
Plexus (PLXS) director Rapp sells 500 shares in planned 10b5-1 trade
Plexus Corp director Karen Marie Rapp sold 500 shares of common stock at $195.59 per share on February 27, 2026. This transaction was executed under a pre-arranged Rule 10b5-1 trading plan adopted on February 28, 2024. Following the sale, Rapp directly holds 8,535 Plexus shares, representing a slight decrease in her direct ownership.
PLXS SEC Filings - Plexus Corp 10-K, 10-Q, 8-K Forms
This page provides a comprehensive resource for Plexus SEC filings, including 10-K, 10-Q, and 8-K forms, accessible to investors and traders. Stock Titan offers AI-powered summaries to highlight key information from these documents, along with real-time updates from the SEC’s EDGAR system. The article details recent insider transactions and proposed sales of shares by executives and other holders.
Plexus Corp. $PLXS Shares Bought by JPMorgan Chase & Co.
JPMorgan Chase & Co. has increased its stake in Plexus Corp. (NASDAQ:PLXS) by 28.3% in Q3, now owning 240,460 shares valued at approximately $34.79 million. Despite significant institutional buying, corporate insiders have sold nearly $9.62 million in shares, reducing their ownership to 1.78%. Plexus reported an EPS beat and 9.6% revenue growth, with analysts maintaining a "Moderate Buy" rating and a consensus price target of $189.20.
Insider Sell Alert: Michael Running Sells 700 Shares of Plexus C
Michael Running, Regional President - AMER of Plexus Corp (PLXS), sold 700 shares on February 25, 2026, bringing his total holdings to 1,175 shares. This transaction follows a pattern of 40 insider sells and no insider buys for Plexus Corp over the past year. The stock is considered significantly overvalued with a price-to-GF-Value ratio of 1.59, trading at $205.47 against a GF Value of $128.83.
Plexus (PLXS) director Randy Martinez sells 1,000 common shares
Plexus Corp. director Randy J. Martinez sold 1,000 common shares on February 25, 2026, at an average price of $203.1401 per share. Following this open-market transaction, Martinez directly owns 5,201 Plexus shares. The transaction was reported in a Form 4 SEC filing, indicating a moderate impact and negative sentiment on the sale.
[144] PLEXUS CORP SEC Filing
This article reports on a Plexus Corp (PLXS) SEC Form 144 filing from February 25, 2026, detailing a proposed sale of securities. The filing indicates the sale of 1000 shares of common stock at an aggregate market value of $203,140.10, acquired on February 3, 2026, as restricted stock from the Issuer. The document provides Filer, Issuer, and Securities information, emphasizing that the individual selling the securities has no material adverse information about the issuer that has not been publicly disclosed.
[144] PLEXUS CORP SEC Filing
This article reports on a Form 144 SEC filing by Plexus Corp (PLXS), detailing an insider sale by Michael J. Running. The filing indicates the sale of 926 common shares for $189,756.01 on February 2, 2026, and lists performance-share line items. The article provides specifics of the filing, including issuer information and details regarding the securities sold.
Hear Plexus management in live Raymond James investor fireside chat
Plexus (NASDAQ: PLXS) announced it will participate in the Raymond James 47th Annual Institutional Investors Conference on March 2, 2026, in Orlando. A fireside chat with Plexus' management team is scheduled for 10:25 a.m. ET and will be available via live webcast with a 90-day replay. The announcement, published on February 23, 2026, highlighted key details for investors interested in the presentation.
[Form 4] PLEXUS CORP Insider Trading Activity
Plexus Corp executive Angelo Michael Ninivaggi Jr. reported equity compensation activity, including the grant of 975 Performance Stock Units (PSUs) on February 17, 2026, and the conversion of 3,275 PSUs into common stock. Following the conversion, 1,540 common shares were disposed of for tax withholding. After these transactions, Ninivaggi directly owned 21,834 shares of Plexus common stock.
Plexus exec VP Mihm sells $2.36 million in PLXS stock
Oliver K. Mihm, Executive Vice President and COO of PLEXUS CORP (NASDAQ:PLXS), sold 11,767 shares of company stock for approximately $2.36 million on February 17 and 18, 2026. These sales occurred after a significant stock gain, with the stock currently indicated as overvalued. In related news, Plexus Corp. reported strong financial results for Q1 fiscal year 2026, exceeding EPS expectations and meeting revenue forecasts.
Plexus CEO Kelsey sells $1m+ in PLXS stock
Plexus Corp (NASDAQ:PLXS) CEO Todd P. Kelsey sold 5,231 shares of company stock for over $1 million, executed under a pre-arranged Rule 10b5-1 trading plan. Prior to this, Kelsey acquired 18,726 shares through exercised performance stock units and disposed of 8,802 shares to cover tax obligations. These transactions come as Plexus's stock shows strong performance, and the company recently reported solid first-quarter fiscal year 2026 financial results, with EPS and revenue meeting or exceeding expectations.
